ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 890

$690K Total Retail Price of All Prescriptions

Rank: 149 out of 890

676 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 718 597 1 4
SIMVASTATIN 619 591 2 5
PRAVASTATIN SODIUM 609 497 3 10
METFORMIN HCL 569 470 4 6
LEVOTHYROXINE SODIUM 551 489 5 2
OMEPRAZOLE 514 394 6 8
ATORVASTATIN CALCIUM 375 290 7 13
AMLODIPINE BESYLATE 355 304 8 1
HYDROCHLOROTHIAZIDE 301 261 9 9
HYDROCODONE-ACETAMINOPHEN 299 234 S3 10 3
METOPROLOL SUCCINATE 281 255 11 17
FUROSEMIDE 247 223 12 7
ATENOLOL 231 182 13 23
ALLOPURINOL 227 186 14 31
ALENDRONATE SODIUM 208 199 15 38
CARVEDILOL 188 166 16 22
FLUTICASONE PROPIONATE 186 154 17 39
SERTRALINE HCL 178 133 18 26
LOSARTAN POTASSIUM 176 164 19 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 154 20 21
CITALOPRAM HBR 151 120 21 20
PANTOPRAZOLE SODIUM 150 106 22 34
POTASSIUM CHLORIDE 146 138 23 11
GLIMEPIRIDE 144 107 24 27
ZOLPIDEM TARTRATE 141 88 25 19
AMITRIPTYLINE HCL 136 90 R 26 43
CLOPIDOGREL 136 106 26 28
BENAZEPRIL HCL 128 121 28 44
GABAPENTIN 123 120 29 12
METOPROLOL TARTRATE 114 74 30 15
MELOXICAM 112 105 31 18
GLIPIZIDE 103 95 32 62
PLAVIX 96 75 33 42
SYNTHROID 91 81 34 53
METFORMIN HCL ER 91 71 34 54
LANTUS SOLOSTAR 89 37 36 102
DONEPEZIL HCL 87 87 37 30
ADVAIR DISKUS 86 80 38 52
FOSINOPRIL SODIUM 83 82 39 184
TAMSULOSIN HCL 83 71 39 32
LOVASTATIN 82 65 41 46
PAROXETINE HCL 81 66 42 68
CRESTOR 75 44 43 25
TRIAMTERENE-HCTZ 75 69 43 61
TRAZODONE HCL 75 64 43 40
PEN NEEDLE 73 48 46 135
DIOVAN 71 67 47 33
FLUOXETINE HCL 70 54 48 63
ESTRADIOL 69 42 R 49 118
FINASTERIDE 68 68 50 108
QUINAPRIL HCL 68 49 50 116
WARFARIN SODIUM 66 57 52 24
CLONIDINE HCL 65 51 53 35
SPIRIVA 65 65 53 66
VERAPAMIL ER 65 56 53 87
ROPINIROLE HCL 64 56 56 93
PROPRANOLOL HCL 64 53 56 141
GLYBURIDE 63 48 R 58 83
CYMBALTA 63 30 58 45
COMBIVENT 63 35 58 144
FENOFIBRATE 63 47 58 74
ZETIA 62 62 62 81
KLOR-CON M20 59 59 63 72
OXYBUTYNIN CHLORIDE ER 57 57 64 154
TRAMADOL HCL 56 42 65 16
DOXAZOSIN MESYLATE 54 50 66 70
NEXIUM 52 37 67 14
CYCLOBENZAPRINE HCL 51 19 R 68 64
RAMIPRIL 50 50 69 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.